Lymphocyte and neutrophil dysfunction associated with hepatitis B virus and hepatitis non‐A, non‐B virus infection in the chimpanzee

Autor: K.A. Wright, Cummins L, Louis J. Lafrado, Marr Jm, Javadian Ma, Charlene S. Dezzutti, Richard G. Olsen, Kelliher Jc

Publikováno v: Journal of Medical Primatology. 20:302-307

Chimpanzees were examined for the effect of viral hepatitis infections on specific and nonspecific immune response mechanisms. The data suggest that infection with either hepatitis B virus or hepatitis non-A, non-B virus may result in suppression of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::88ed6def9d0e264a234bccf9f253c21f
https://doi.org/10.1111/j.1600-0684.1991.tb00540.x

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Atp1a2 and Kcnj9 are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains.

Autor: Goldberg LR; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA., Baskin BM; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; T32 Training Program on Development of Medications for Substance Use Disorder, Center for Drug Discovery, Northeastern University., Adla Y; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Beierle JA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University., Kelliher JC; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Yao EJ; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Kirkpatrick SL; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Reed ER; Graduate Program in Bioinformatics, Boston University, Boston, MA USA., Jenkins DF; Graduate Program in Bioinformatics, Boston University, Boston, MA USA., Cox J; Genetics and Graduate Program in Genetics and Genomics, Program in Biomedical Sciences, Boston University Chobanian & Avedisian School of Medicine., Luong AM; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Luttik KP; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Scotellaro JA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Undergraduate Research Opportunity Program (UROP), Boston University., Drescher TA; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Crotts SB; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA., Yazdani N; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; Graduate Program in Biomolecular Pharmacology, Department of Pharmacology, Physiology & Biophysics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA USA.; Transformative Training Program in Addiction Science, Boston University., Ferris MT; Department of Genetics, University of North Carolina, Chapel Hill, NC USA., Johnson WE; Division of Infectious Disease, Department of Medicine, Center for Data Science, Rutgers University, New Jersey, USA., Mulligan MK; Department of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN USA., Bryant CD; Laboratory of Addiction Genetics, Department of Pharmaceutical Sciences and Center for Drug Discovery, Northeastern University, Boston, MA USA.; T32 Training Program on Development of Medications for Substance Use Disorder, Center for Drug Discovery, Northeastern University.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.

Sex Differences in Behavioral and Brainstem Transcriptomic Neuroadaptations following Neonatal Opioid Exposure in Outbred Mice.

Autor: Borrelli KN; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Graduate Program for Neuroscience, Boston University, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Yao EJ; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Yen WW; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215., Phadke RA; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215.; Molecular Biology, Cell Biology, and Biochemistry (MCBB), Boston University, Boston, Massachusetts 02215., Ruan QT; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Chen MM; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Kelliher JC; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Langan CR; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Scotellaro JL; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Undergraduate Research Opportunity Program, Boston University, Boston, Massachusetts 02118., Babbs RK; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118., Beierle JC; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118.; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts 02118.; NIGMS Training Program in Biomolecular Pharmacology, Boston University School of Medicine, Boston, Massachusetts 02118., Logan RW; Laboratory of Sleep, Rhythms, and Addiction, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118.; Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, Bar Harbor, Maine 04609., Johnson WE; Department of Medicine, Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts 02118., Wachman EM; Department of Pediatrics, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts 02118., Cruz-Martín A; Neurobiology Section, Department of Biology, Boston University, Boston, Massachusetts 02215., Bryant CD; Laboratory of Addiction Genetics, Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118 camron@bu.edu.

Publikováno v: ENeuro [eNeuro] 2021 Sep 20; Vol. 8 (5). Date of Electronic Publication: 2021 Sep 20 (Print Publication: 2021).